-+ 0.00%
-+ 0.00%
-+ 0.00%

SILEXION THERAPEUTICS CORP - SIL204 ACHIEVES 90% INHIBITION RATE IN GP2D COLORECTAL CANCER CELLS

Reuters·05/29/2025 13:05:00

Please log in to view news